Latest Industry Insights
Industry Insight
From Hits to Leads: Improving Early Drug Discovery With Better Tools
In this interview, Dr. Iain Yisu Wang from MedChemExpress discusses the growing role of AI, the value of phenotypic screening and how tailored compound libraries are helping researchers keep up with the increasing complexity of drug discovery.
Industry Insight
AI-Enabled Spatial Proteomics Improves Prediction of Progression to Cancer
We spoke with Castle Bioscience's Dr. Rebecca Critchley-Thorne about AI-enabled spatial proteomics, TissueCypher’s impact on Barrett’s esophagus management and its broader potential for precision oncology.
Industry Insight
Lab of the Future Europe 2025: Transforming Life Science Research
From AI to digital laboratories, discover how new technologies are shaping the future of science at Lab of the Future Europe 2025.
Industry Insight
Deep Visual Proteomics Reveals New Drug Targets in Lethal Skin Disease
Learn how scientists mapped the protein landscape of toxic epidermal necrolysis, a lethal skin disease, a lethal skin disease, by applying Deep Visual Proteomics, leading to the use of JAK inhibitors with life-saving results.
Industry Insight
Building the Next Generation of Genetic Medicines With LNPs
A recent milestone study used the LNP delivery system developed by Acuitas Therapeutics to treat a newborn with urea cycle disorder (UCD) successfully with a personalized CRISPR therapy. We spoke to Dr. Ying Tam, their CSO, to find out more.
Industry Insight
AI and Synthetic Biology: Balancing Innovation With Biosecurity
AI is revolutionizing biotechnology innovation, but industry stakeholders must work together to mitigate its risks. In this article, Adam Clore explores the role of nucleic acid biosecurity screening tools and how they can be improved.
Industry Insight
From Policy to Practice: How Human-Based In Vitro Models Are Reshaping Discovery
Discover how scalable, human-based in vitro models are reshaping discovery pipelines, balancing complexity with reproducibility, and enabling new kinds of experimentation that go beyond the limits of animal research.
Industry Insight
From Bench to Boardroom: Leading Cell and Gene Therapy Through Uncertainty
In this opinion piece, Dr. Stella Vnook explores how cell and gene therapy leaders are adapting to today’s financial and regulatory headwinds, offering actionable insights into how biotech CEOs are rethinking capital strategy.
Industry Insight
New Partnership Will Probe the Connection Between Tau Protein and Alzheimer’s
Technology Networks spoke with Nautilus Biotechnology and the Allen Institute about their new agreement to advance Alzheimer’s research through proteoform analysis.
Industry Insight
Engineering Immune Responses: Protein Design for the Next Era of Cancer Therapy
Dr. Jamie Spangler gives a vision of how engineered proteins could overcome the toughest challenges in cancer immunotherapy.
Advertisement